These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31548396)

  • 1. Task-based fMRI predicts response and remission to exposure therapy in obsessive-compulsive disorder.
    Pagliaccio D; Middleton R; Hezel D; Steinman S; Snorrason I; Gershkovich M; Campeas R; Pinto A; Van Meter P; Simpson HB; Marsh R
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20346-20353. PubMed ID: 31548396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network-based functional connectivity predicts response to exposure therapy in unmedicated adults with obsessive-compulsive disorder.
    Shi TC; Pagliaccio D; Cyr M; Simpson HB; Marsh R
    Neuropsychopharmacology; 2021 Apr; 46(5):1035-1044. PubMed ID: 33446895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural neural markers of response to cognitive behavioral therapy in pediatric obsessive-compulsive disorder.
    Pagliaccio D; Cha J; He X; Cyr M; Yanes-Lukin P; Goldberg P; Fontaine M; Rynn MA; Marsh R
    J Child Psychol Psychiatry; 2020 Dec; 61(12):1299-1308. PubMed ID: 31889307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral avoidance predicts treatment outcome with exposure and response prevention for obsessive-compulsive disorder.
    Wheaton MG; Gershkovich M; Gallagher T; Foa EB; Simpson HB
    Depress Anxiety; 2018 Mar; 35(3):256-263. PubMed ID: 29394511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximizing remission from cognitive-behavioral therapy in medicated adults with obsessive-compulsive disorder.
    Simpson HB; Foa EB; Wheaton MG; Gallagher T; Gershkovich M; Schmidt AB; Huppert JD; Campeas RB; Imms PA; Cahill SP; DiChiara C; Tsao SD; Puliafico AC; Chazin D; Asnaani A; Moore K; Tyler J; Steinman SA; Sanchez-LaCay A; Capaldi S; Snorrason I; Turk-Karan E; Vermes D; Kalanthroff E; Pinto A; Hahn CG; Xu B; Van Meter PE; Katechis M; Scodes J; Wang Y
    Behav Res Ther; 2021 Aug; 143():103890. PubMed ID: 34089924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.
    Foa EB; Simpson HB; Rosenfield D; Liebowitz MR; Cahill SP; Huppert JD; Bender J; McLean CP; Maher MJ; Campeas R; Hahn CG; Imms P; Pinto A; Powers MB; Rodriguez CI; Van Meter PE; Vermes D; Williams MT
    J Clin Psychiatry; 2015 Apr; 76(4):440-6. PubMed ID: 25375780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Brain Network Connections After Exposure and Response Prevention Therapy for Obsessive-Compulsive Disorder in Adolescents and Adults.
    Becker HC; Beltz AM; Himle JA; Abelson JL; Block SR; Taylor SF; Fitzgerald KD
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 Jan; 9(1):70-79. PubMed ID: 37820789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of symptom dimensions on outcome for exposure and ritual prevention therapy in obsessive-compulsive disorder.
    Williams MT; Farris SG; Turkheimer EN; Franklin ME; Simpson HB; Liebowitz M; Foa EB
    J Anxiety Disord; 2014 Aug; 28(6):553-8. PubMed ID: 24983796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response versus remission in obsessive-compulsive disorder.
    Simpson HB; Huppert JD; Petkova E; Foa EB; Liebowitz MR
    J Clin Psychiatry; 2006 Feb; 67(2):269-76. PubMed ID: 16566623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges using motivational interviewing as an adjunct to exposure therapy for obsessive-compulsive disorder.
    Simpson HB; Zuckoff AM; Maher MJ; Page JR; Franklin ME; Foa EB; Schmidt AB; Wang Y
    Behav Res Ther; 2010 Oct; 48(10):941-8. PubMed ID: 20609435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obsessive compulsive personality disorder as a predictor of exposure and ritual prevention outcome for obsessive compulsive disorder.
    Pinto A; Liebowitz MR; Foa EB; Simpson HB
    Behav Res Ther; 2011 Aug; 49(8):453-8. PubMed ID: 21600563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial.
    Russman Block S; Norman LJ; Zhang X; Mannella KA; Yang H; Angstadt M; Abelson JL; Himle JA; Taylor SF; Fitzgerald KD
    Am J Psychiatry; 2023 Jan; 180(1):89-99. PubMed ID: 36475374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient adherence predicts outcome from cognitive behavioral therapy in obsessive-compulsive disorder.
    Simpson HB; Maher MJ; Wang Y; Bao Y; Foa EB; Franklin M
    J Consult Clin Psychol; 2011 Apr; 79(2):247-252. PubMed ID: 21355639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.
    McLean CP; Zandberg LJ; Van Meter PE; Carpenter JK; Simpson HB; Foa EB
    J Clin Psychiatry; 2015 Dec; 76(12):1653-7. PubMed ID: 26613263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: an open pilot trial.
    Simpson HB; Zuckoff A; Page JR; Franklin ME; Foa EB
    Cogn Behav Ther; 2008; 37(1):38-49. PubMed ID: 18365797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient adherence and treatment outcome with exposure and response prevention for OCD: Which components of adherence matter and who becomes well?
    Wheaton MG; Galfalvy H; Steinman SA; Wall MM; Foa EB; Simpson HB
    Behav Res Ther; 2016 Oct; 85():6-12. PubMed ID: 27497840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects.
    Gershkovich M; Middleton R; Hezel DM; Grimaldi S; Renna M; Basaraba C; Patel S; Simpson HB
    Behav Ther; 2021 Mar; 52(2):394-405. PubMed ID: 33622508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability, Feasibility, and Effectiveness of Internet-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in New York.
    Patel SR; Wheaton MG; Andersson E; Rück C; Schmidt AB; La Lima CN; Galfavy H; Pascucci O; Myers RW; Dixon LB; Simpson HB
    Behav Ther; 2018 Jul; 49(4):631-641. PubMed ID: 29937263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental aspects of error and high-conflict-related brain activity in pediatric obsessive-compulsive disorder: a fMRI study with a Flanker task before and after CBT.
    Huyser C; Veltman DJ; Wolters LH; de Haan E; Boer F
    J Child Psychol Psychiatry; 2011 Dec; 52(12):1251-60. PubMed ID: 21793825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial.
    Lewin AB; Park JM; Jones AM; Crawford EA; De Nadai AS; Menzel J; Arnold EB; Murphy TK; Storch EA
    Behav Res Ther; 2014 May; 56():30-8. PubMed ID: 24657310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.